First Republic Investment Management, Inc. Crispr Therapeutics Ag Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

A detailed history of First Republic Investment Management, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 6,751 shares of CRSP stock, worth $229,736. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,751

Previous 6,651 1.5%

Holding current value

$229,736

Previous $373,000 17.96%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$45.39 - $59.0 $4,539 - $5,900	100 Added 1.5%	6,751 $306,000
Q2 2023 Jul 28, 2023	SELL	$43.47 - $67.77 $33,950 - $52,928	-781 Reduced 10.51%	6,651 $373,000
Q1 2023 May 11, 2023	BUY	$41.0 - $56.12 $304,712 - $417,083	7,432 New	7,432 $336,000
Q3 2022 Nov 03, 2022	SELL	$61.1 - $83.78 $45,580 - $62,499	-746 Reduced 13.02%	4,983 $326,000
Q2 2022 Aug 16, 2022	SELL	$43.23 - $73.83 $75,652 - $129,202	-1,750 Reduced 23.4%	5,729 $348,000
Q1 2022 May 16, 2022	SELL	$53.19 - $79.24 $16,382 - $24,405	-308 Reduced 3.96%	7,479 $469,000
Q4 2021 Feb 09, 2022	SELL	$70.09 - $111.29 $891,124 - $1.41 Million	-12,714 Reduced 62.02%	7,787 $590,000
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $11.1 Million - $15.8 Million	-101,090 Reduced 83.14%	20,501 $2.3 Million
Q2 2021 Aug 16, 2021	BUY	$100.84 - $161.89 $11.7 Million - $18.8 Million	116,360 Added 2224.43%	121,591 $19.7 Million
Q1 2021 May 14, 2021	SELL	$110.72 - $210.04 $6.31 Million - $12 Million	-56,985 Reduced 91.59%	5,231 $637,000
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $4.13 Million - $8.97 Million	51,778 Added 496.05%	62,216 $9.53 Million
Q3 2020 Nov 12, 2020	BUY	$78.5 - $100.64 $556,565 - $713,537	7,090 Added 211.77%	10,438 $873,000
Q2 2020 Aug 13, 2020	BUY	$38.5 - $76.05 $128,898 - $254,615	3,348 New	3,348 $246,000
Q1 2020 May 13, 2020	SELL	$33.68 - $62.53 $162,438 - $301,582	-4,823 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $176,907 - $352,705	4,823 New	4,823 $294,000

Others Institutions Holding CRSP

# of Institutions

487

Shares Held

64.1M

Call Options Held

1.64M

Put Options Held

1.93M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $2.65B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account

First Republic Investment Management, Inc. Crispr Therapeutics Ag Transaction History